Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Averna Therapeutics Inc.

Averna Therapeutics Inc.

Stage unknownWatertown, MAOther Health Care
Facts
Year of incorporation
2022sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Apr 8, 2024
    Form D equity offering · $38.8M (form d sold) · 13 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Exsilio Therapeutics Inc. filed Form D: $38,769,227 sold of $85,000,000, Other Health Care
Investors on record
0 edges
No named investor yet.
People
8 officers, 15 directors
Timeline
3
  1. Mar 20, 2026
    Averna Therapeutics Inc. filed Form D/A: $84,999,995 sold of $85,000,000, Other Health Care
  2. Apr 21, 2025
    Averna Therapeutics Inc. filed Form D/A: $43,769,227 sold of $85,000,000, Other Health Care
  3. Apr 17, 2024
    Exsilio Therapeutics Inc. filed Form D: $38,769,227 sold of $85,000,000, Other Health Care
Evidence
45 observations
Every observation on this company